NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 142 filers reported holding NEVRO CORP in Q1 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $18,472,000 | -60.0% | 324,063 | -44.0% | 0.29% | -62.1% |
Q2 2018 | $46,220,000 | -14.1% | 578,841 | -6.8% | 0.78% | -15.9% |
Q1 2018 | $53,806,000 | +40.6% | 620,813 | +12.0% | 0.92% | +41.5% |
Q4 2017 | $38,268,000 | -14.4% | 554,283 | +12.7% | 0.65% | -16.5% |
Q3 2017 | $44,712,000 | +7.2% | 491,988 | -12.2% | 0.78% | +6.8% |
Q2 2017 | $41,723,000 | +5.1% | 560,568 | +32.4% | 0.73% | +3.4% |
Q1 2017 | $39,684,000 | +23.7% | 423,518 | -4.1% | 0.71% | +17.5% |
Q4 2016 | $32,085,000 | -15.4% | 441,583 | +21.5% | 0.60% | -11.9% |
Q3 2016 | $37,947,000 | +62.3% | 363,508 | +14.7% | 0.68% | +61.2% |
Q2 2016 | $23,375,000 | +22.2% | 316,908 | -6.8% | 0.42% | +28.6% |
Q1 2016 | $19,134,000 | -17.3% | 340,093 | -0.8% | 0.33% | -13.2% |
Q4 2015 | $23,136,000 | -34.0% | 342,703 | -54.6% | 0.38% | -31.8% |
Q3 2015 | $35,034,000 | -3.9% | 755,206 | +11.3% | 0.56% | +12.6% |
Q2 2015 | $36,470,000 | +474.9% | 678,515 | +412.6% | 0.49% | +541.6% |
Q1 2015 | $6,344,000 | +24.0% | 132,355 | 0.0% | 0.08% | +28.3% |
Q4 2014 | $5,118,000 | – | 132,355 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRAIDWELL LP | 1,776,368 | $45,155,275 | 1.48% |
ARMISTICE CAPITAL, LLC | 2,356,000 | $59,889,520 | 0.87% |
Rock Springs Capital Management LP | 1,211,400 | $30,793,788 | 0.73% |
ArrowMark Colorado Holdings LLC | 1,817,189 | $46,192,944 | 0.51% |
Palo Alto Investors LP | 186,259 | $4,734,704 | 0.38% |
K2 PRINCIPAL FUND, L.P. | 51,000 | $1,296,420 | 0.30% |
TD Capital Management LLC | 84,648 | $2,151,752 | 0.26% |
Point72 Europe (London) LLP | 73,800 | $1,875,996 | 0.25% |
Venator Management LLC | 25,000 | $636 | 0.23% |
Virtus Investment Advisers, Inc. | 12,500 | $317,750 | 0.22% |